Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is not fully prepared for another pandemic or widespread health crisis, though it has made notable improvements in some areas since COVID-19 and has tools and plans that could enable better readiness with sustained action. Expert assessments, government reports, and bipartisan reviews consistently highlight progress alongside persistent and, in some cases, worsening gaps in leadership continuity, funding, coordination, infrastructure, stockpiles for all threats, supply chains, surveillance integration, public health workforce, and societal factors like trust.[1]
Progress Since COVID-19
The US has addressed some COVID-era failures:
These steps mean the US is better positioned in technology platforms, certain data systems, and documented playbooks than in early 2020.
Persistent and Emerging Gaps
Multiple authoritative sources conclude the nation remains vulnerable:
Experts (e.g., in The BMJ, NEJM, Stimson Center, academic analyses) note a historical pattern of forgetting lessons after outbreaks (H1N1, Ebola, Zika, COVID), with implementation lagging ideas. The US ranked highly on some pre-COVID indices yet performed poorly by many metrics due to execution failures.[12]
Broader Context and Outlook
Pandemics and health crises (including antimicrobial resistance, climate-linked diseases, or bioterror) are inevitable and potentially more severe. Strengths in innovation, private sector, and federal resources exist, but success requires consistent funding (not just emergency spikes), bipartisan political will, domestic manufacturing resilience, integrated One Health (human-animal-environment) approaches, equity focus, clear authorities, regular exercises, and rebuilding trust/communication. Global cooperation remains important since threats cross borders.
In short, the US has blueprints, some rebuilt capacity, and technological edges, making it more prepared than in 2019 in targeted ways—but incomplete reforms, funding gaps, coordination shortfalls, and variable attention mean it is not adequately ready for a major event on the scale of (or worse than) COVID-19. Sustained implementation of existing recommendations (GAO, Biodefense Commission, etc.) could close many gaps relatively quickly. Ongoing monitoring of threats like H5N1 and respiratory seasons continues via CDC systems.
Citations (12)
- https://www.bmj.com/content/384/bmj.q332%20
Backs: “Expert assessments, government reports, and bipartisan reviews consistently highlight progress alongside persistent and, in some cases, worsening gaps in leadership continuity, funding, coordination, infrastructure, stockpiles for all threats, supply chains, surveillance integration, public health workforce, and…”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “Investments advanced mRNA and other platform technologies for faster vaccine/therapeutic development (e.g., BARDA funding for next-gen flu vaccines).”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “Significant expansions occurred in wastewater surveillance (National Wastewater Surveillance System), electronic case reporting (tens of thousands of facilities now automated vs. hundreds pre-COVID), syndromic surveillance, and genomic/traveler-based monitoring. CDC has partnerships for rapid diagnostics.”
- https://www.presidency.ucsb.edu/documents/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response
Backs: “BARDA transitioned medical countermeasures (MCMs) into the SNS.”
- https://www.presidency.ucsb.edu/documents/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report
Backs: “Global health security investments exceeded $3 billion since 2020 in some tallies.”
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “COVID’s toll (over 1 million US deaths) showed the cost of inaction. Apathy and on-again/off-again attention persist.”
- https://www.gao.gov/products/gao-24-107175
Backs: “Lessons emphasize advance planning with clear roles, partner collaboration, clear communications, data collection/sharing, leveraging infrastructure, and flexibilities—but implementation lags.”
- https://www.homelandsecuritynewswire.com/dr20230424-pandemic-preparedness-policy
Backs: “Only limited approved MCMs exist for high-risk viral families; research/funding often peaks post-outbreak then declines.”
- https://www.commonwealthfund.org/blog/2023/lessons-covid-19-can-help-us-prepare-next-pandemic
Backs: “Adult vaccine access systems have gaps post-emergency funding.”
- https://www.notus.org/health-science/white-house-pandemic-preparedness
Backs: “Recent developments (as of 2025–2026 reporting) include periods of OPPR understaffing or vacancy after transitions, program cuts or shifts at NIH/CDC biodefense/pandemic efforts, database discontinuations, and reduced emphasis on certain global collaborations—raising concerns about backsliding.”
- https://www.foreignaffairs.com/united-states/world-not-ready-next-pandemic
Backs: “Global readiness is also insufficient, affecting the US via interconnected risks.”
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “The US ranked highly on some pre-COVID indices yet performed poorly by many metrics due to execution failures.”